Zhao, Chunyan
Song, Chang
Zhou, Yue
Luo, Jing
Zheng, Shaochu
Li, Xiaojuan
Dang, Yuhai
Yang, Nuo
Kong, Jinliang
Funding for this research was provided by:
Key Research Program of Guangxi Science and Technology Department (AB21196010)
Self-funded Scientific Research Project of the Health Commission of Guangxi Zhuang Autonomous Region (No.Z-A20240492, Z-A20240515)
National Natural Science Foundation of China (82104499, 82160783)
Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation (No.2023GXNSFBA026146)
China Postdoctoral Science Foundation (2023MD734158)
Article History
Received: 17 December 2025
Accepted: 5 May 2026
First Online: 18 June 2026
Declarations
:
: This study was approved by the Medical Ethics Review Committee of the First Affiliated Hospital of Guangxi Medical University (2025-K0216). This study is based on data derived from original clinical trials that have obtained approval from relevant ethics review committees, strictly adhere to the principles of the Declaration of Helsinki and international standards for Good Clinical Practice (GCP), and have completed participant informed consent processes. The INFORMA database solely aggregates and processes anonymized trial project information that has undergone compliant de-identification procedures. It does not involve direct contact with patients or the collection of new personal data. Consequently, this study itself does not involve new human subjects, and its use of data is in compliance with ethical requirements for information obtained from legally and ethically compliant sources.
: Not applicable.
: The authors declare no competing interests.